Relevant bibliographies by topics / Drepanoalpha®

Contents

  1. Journal articles

Academic literature on the topic 'Drepanoalpha®'

Author: Grafiati
Published: 3 June 2025
Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Drepanoalpha®.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Drepanoalpha®"

1

Benjamin, Z. Gbolo, S. T. Tshibangu Damien, Memvanga Patrick, et al. "Assessment of the Efficacy and Tolerance of Drepanoalpha® in the Management of Sickle Cell Disease in Kinshasa (DR Congo): About Ten Cases." International Journal of Medical and Pharmaceutical Case Reports 9, no. 2 (2017): 1–10. https://doi.org/10.9734/IJMPCR/2017/33658.

Full text
Abstract:
<strong>Aims: </strong>The aim of this study is to assess the efficacy and safety of Drepanoalpha®, a nutraceutical used in the management of sickle cell disease in DR Congo. <strong>Study Design:</strong> Drepanoalpha® to ten sickle patients, evaluation of parameters before and after treatment. <strong>Place and Duration of Study:</strong> Department of Biology, Science faculty, university of Kinshasa, between Sept 2015 and July 2016. <strong>Methodology:</strong> The ten selected cases were submitted to Drepanoalpha® for two months and the following parameters were observed before, during an
APA, Harvard, Vancouver, ISO, and other styles
2

Gbolo, Benjamin, Damien Tshibangu, Lionel Asamboa, et al. "Sickle Cell Anemia Therapeutic Approach Based on Drepanoalpha®: About 34 Cases." Journal of Complementary and Alternative Medical Research 4, no. 2 (2017): 1–8. http://dx.doi.org/10.9734/jocamr/2017/37350.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Gbolo Zoawe, Benjamin, Amandine Nachtergael, Damien S. T. Tshibangu, et al. "In Vitro Biological Activities of Drepanoalpha® Ethanolic Extract, A Justicia Secunda and Moringa Oleifera-Based Phytomedicine Proposed for The Symptomatic Treatment of Sickle Cell Disease." Journal of Fundamental and Applied Pharmaceutical Science 3, no. 2 (2023): 64–82. http://dx.doi.org/10.18196/jfaps.v3i2.16000.

Full text
Abstract:
Sickle cell disease (SCD) is an autosomal recessive blood disorder characterized by red blood cells that assume an abnormal, rigid sickle shape under low-oxygen conditions. These sickle-shaped erythrocytes tend to lyse, aggregate, and obstruct small blood vessels, leading to major complications. The present study aims to investigate properties that may underlie the activity of Drepanoalphaâ, an antisickling herbal formulation developed in the Democratic Republic of Congo (DRC) for the prevention and symptomatic treatment of sickle cell disease crises. The Drepanoalpha® Ethanolic Extract (DEE)
APA, Harvard, Vancouver, ISO, and other styles
4

Gbolo, Benjamin Zoawe, Bobette Nkongolo Ciala, Jean-Paul Koto-Te-Nyiwa Ngbolua, et al. "Profilage phytochimique par chromatographie sur couche mince haute performance d’extraits de flavonoïdes totaux du Drepanoalpha® et évaluation de leur activité anti-drépanocytaire in vitro." Annales Africaines de Medecine 16, no. 1 (2022): 4882–98. http://dx.doi.org/10.4314/aamed.v16i1.3.

Full text
Abstract:
Contexte et objectif. Le défi le plus important dans la drépanocytose consiste à améliorer l’état de santé des patients dans les pays en développement. L'une des meilleures solutions est donc le développement de la phytomédecine basée sur la connaissance de la pharmacopée traditionnelle. L’objectif de la présente étude était d’évaluer les activités anti-drépanocytaires des flavonoïdes totaux extraits du phytomédicament Drépanoalpha® d’une part et déterminer leur profilage chimique par chromatographie sur couche mince haute performance d’autre part. Méthodes. Les flavonoïdes totaux ont été obte
APA, Harvard, Vancouver, ISO, and other styles
5

Gbolo, Benjamin, Damien Tshibangu, Patrick Memvanga, et al. "Assessment of the Efficacy and Tolerance of Drepanoalpha® in the Management of Sickle Cell Disease in Kinshasa (DR Congo): About Ten Cases." International Journal of Medical and Pharmaceutical Case Reports 9, no. 2 (2017): 1–10. http://dx.doi.org/10.9734/ijmpcr/2017/33658.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Ngbolua, K., P. Mpiana, D. Tshibangu, et al. "In vitro Antisickling and Radical Scavenging Activities of a Poly-herbal Formula (Drepanoalpha®) in Sickle Cell Erythrocyteand Acute Toxicity Study in Wistar Albino Rats." European Journal of Medicinal Plants 4, no. 10 (2014): 1251–67. http://dx.doi.org/10.9734/ejmp/2014/11861.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Mpiana, P., F. Kasali, F. Bwirhonde, et al. "Acute and Sub-acute Oral Toxicity Study of Drepanoalpha® (A Poly-Herbal Formula Used in the Management of Sickle Cell Disease) in Guinea-pigs." British Journal of Pharmaceutical Research 10, no. 5 (2016): 1–8. http://dx.doi.org/10.9734/bjpr/2016/24200.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Koto-te-Nyiwa, Ngbolua. "The Possible Role of a Congolese polyherbal formula (Drepanoalpha) as source of Epigenetic Modulators in Sickle Cell Disease: A Hypothesis." J. of Advancement in Medical and Life Sciences Volume 2, Issue 1 (2014). https://doi.org/10.5281/zenodo.999159.

Full text
Abstract:
The core message of the present paper is to show how we did to transform indigenous data (Traditional Medicine) into knowledge (Science), and then translate knowledge into innovation. The anti-sickle cell anemia activity of Drepanoalpha® could be due to its epigenetic modulator effect as revealed by the testimony’s of all patients received the product. Drepanoalpha® reduces the frequency of their crises and improves their general state and their hemoglobin level. All the treated patients have normal phenotype if compared them to normal individuals and have not made any more crises for more tha
APA, Harvard, Vancouver, ISO, and other styles
9

Koto-te-Nyiwa, Ngbolua. "Drepanoalpha: An Overview on the Quality Control Process and Standardization Feature of an Antisickling Herbal Drug from Democratic Republic of the Congo." J. of Modern Drug Discovery And Drug Delivery Research Volume 4, Issue 1 (2016). https://doi.org/10.5281/zenodo.891500.

Full text
Abstract:
Sickle cell disease (SCD) is an autosomal recessive type of hemoglobin disorder. Nowadays, the main challenge is how to improve the clinical aspects of life quality of the patients with low toxicity and safer therapy from indigenous knowledge. Democratic Republic of the Congo is one of the biodiversity rich countries in the world and can play the lead role in production and commercialization of standardized antisickling formulations like Drepanoalpha® worldwide. In this research paper, various methods of phytochemical standardization, such as TLC, HPTLC, HPLC, UV-Vis, IR, MS and their hyphenat
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography